Skin human papillomavirus type 38 alters p53 functions by accumulation of ΔNp73

EMBO Reports

Volumn 7, Issue 3, 2006, Pages 334-340

  Accardi, Rosita ^a   Dong, Wen ^a   Smet, Anouk ^a   Cui, Rutao ^a   Hautefeuille, Agnes ^a   Gabet, Anne Sophie ^a   Sylla, Bakary S ^a   Gissmann, Lutz ^b   Hainaut, Pierre ^a   Tommasino, Massimo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Np73; Cutaneous HPV38; E6 and E7; p53

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ISOPROTEIN; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DELTA NP73; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 38; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; MUTATION; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN ISOFORMS; SKIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; HUMAN PAPILLOMAVIRUS TYPE 38; MUS MUSCULUS; PAPILLOMAVIRIDAE;

EID: 33645766022     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400615     Document Type: Article

References (16)

1. Allart S, Martin H, Detraves C, Terrasson J, Caput D, Davrinche C (2002) Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of ΔN-p73α. J Biol Chem 277: 29063-29068
2. Auewarakul P, Gissmann L, Cidarregui A (1994) Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol Cell Biol 14: 8250-8258
3. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805
4. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, deVilliers E-M, Filotico R, Boukamp P, Tommasino M (2003) The E6 and E7 proteins of cutaneous human papillomavirus type 38 display transforming properties. J Virol 77: 2195-2206
5. Caldeira S, Filotico R, Accardi R, Zehbe I, Franceschi S, Tommasino M (2004) p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers. Cancer Lett 209: 119-124
6. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88: 63-73
7. Concin N et al (2004) Transdominant ΔTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res 64: 2449-2460
8. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324: 17-27
9. Dong W et al (2005) Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 79: 14899-14908
10. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G (2000) The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J Cell Sci 113: 1661-1670
11. Melino G, De Laurenzi V, Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615
12. Petrenko O, Zaika A, Moll UM (2003) ΔNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol 23: 5540-5555
13. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56
14. Terrasson J, Allart S, Martin H, Lule J, Haddada H, Caput D, Davrinche C (2005) p73-dependent apoptosis through death receptor: Impairment by human cytomegalovirus infection. Cancer Res 65: 2787-2794
15. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM (2002) ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196: 765-780
16. zur Hausen H (2002) Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342-350